Category: Company News
-

TurboGen Signs Business Development Agreement With Eric Adams to Expand Global Market Access
TurboGen Ltd. (NASDAQ:TRBG) has signed a strategic business consulting and development agreement with a group including former New York City Mayor Eric Adams, who will join the company’s Advisory Board and support efforts to expand commercial relationships in the U.S. and international markets. Key Investor Takeaways Why TRBG Stock Is in Focus TurboGen has brought…
-

America’s Car-Mart Revenue Falls 57% as Capital Constraints Drive 82% Drop in Retail Sales
America’s Car-Mart (NASDAQ:CRMT) reported a 57.3% decline in first-quarter fiscal 2027 revenue to $145.8 million as capital constraints sharply reduced inventory and vehicle sales, while weaker credit performance and an ongoing review of financing and strategic alternatives add to near-term uncertainty. Key Investor Takeaways Why CRMT Stock Is in Focus America’s Car-Mart’s operating contraction accelerated…
-

Nanox Q2 Revenue Rises 37% as $40.7 Million Impairment Drives Wider GAAP Loss
Nanox (NASDAQ:NNOX) reported a 37% increase in second-quarter 2026 revenue to $4.2 million, but its GAAP net loss widened to $55.5 million following a $40.7 million impairment charge, while cash declined and the company said it intends to continue raising funds. Key Investor Takeaways Why NNOX Stock Is in Focus Nanox’s Q2 revenue growth was…
-

Mint Signs MENA Education Robotics MOU Targeting 3,000-Unit Deployment
Mint Incorporation Limited (NASDAQ:MIMI) said its majority-owned joint venture Rice Robotics AGI has signed a non-binding MENA education robotics MOU with Edvance Innovation, outlining a commercial goal of deploying 3,000 educational robotics units over 36 months and targeting an initial 50-unit purchase order by November 30, 2026. Key Investor Takeaways Why MIMI Stock Is in…
-

Opus Genetics Reports Positive OPGx-BEST1 Phase 1/2 Data, Targets Potential Phase 3 Dosing in 2027
Opus Genetics (NASDAQ:IRD) reported positive low-dose Cohort 1 data from its Phase 1/2 BIRD-1 trial of OPGx-BEST1, alongside FDA alignment on potential pivotal endpoints and a development path that could lead to Phase 3 participant dosing in 2027. Key Investor Takeaways Why IRD Stock Is in Focus The Phase 1/2 data provide the first low-dose…
-

Agroz Strategic Supply Agreement Adds 500+ Acres of Fresh Produce Capacity
Agroz Inc. (NASDAQ:AGRZ) has entered a multi-year strategic supply agreement with Harvest Hive, giving the company access to produce aggregated from more than 500 acres in Malaysia’s Cameron Highlands and supporting additional volume and revenue contribution in the second half of fiscal 2026. Key Investor Takeaways Why AGRZ Stock Is in Focus Agroz has signed…
-

Jaguar Health Launches Neonorm Dog on Amazon, Expanding Animal-Health Product Franchise
The non-prescription digestive-support product extends Jaguar Health’s Neonorm franchise into the companion-animal market, with additional online and retail distribution expected shortly. Key Investor Takeaways Why JAGX Stock Is in Focus Jaguar Health has made Neonorm Dog available on Amazon, marking a concrete commercial step in the expansion of its Neonorm animal-health franchise. The product is…
-

American EcoFuels Appoints Three Independent Directors to Strengthen Board for Commercialization Strategy
The board appointments add experience across capital markets, international business and commercialization as American EcoFuels advances its synthetic fuel development plans. Key Investor Takeaways Why AEFI Stock Is in Focus American EcoFuels has expanded its Board of Directors with three independent appointments as the company prepares for the next stages of its synthetic fuel development…
-

American Fusion Expands Patent Portfolio to 130 Applications as National Exchange Uplisting Plans Advance
The fusion technology developer has reached halfway toward its year-end patent filing target while evaluating TXSE and Nasdaq listing pathways and potential financing options. Key Investor Takeaways Why AMFN Stock Is in Focus American Fusion has expanded its pending U.S. patent portfolio by 30 applications to 130 as it simultaneously advances preparations for a potential…
-

Medical Care Technologies Highlights Multi-Platform AI Strategy Across Health, Enterprise and Consumer Markets
The company is positioning its AI vision technology across several commercial tracks while maintaining operating subsidiaries in auctions and memorabilia authentication. Key Investor Takeaways Why MDCE Stock Is in Focus Medical Care Technologies is emphasizing that its business strategy extends across several AI applications and operating subsidiaries rather than depending on a single product. Its…